Editorial
Nasopharyngeal carcinoma—past lessons and a glimpse into the future
Chinese Clinical Oncology
2016;
5
(2)
:14
.
(19 April 2016)
Review Article
Genetic susceptibility to the endemic form of NPC
Chinese Clinical Oncology
2016;
5
(2)
:15
.
(19 April 2016)
Genetic and epigenetic landscape of nasopharyngeal carcinoma
Chinese Clinical Oncology
2016;
5
(2)
:16
.
(19 April 2016)
MicroRNAs in nasopharyngeal carcinoma
Chinese Clinical Oncology
2016;
5
(2)
:17
.
(19 April 2016)
Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma
Chinese Clinical Oncology
2016;
5
(2)
:18
.
(19 April 2016)
Evolution of the Chinese staging system for nasopharyngeal carcinoma
Chinese Clinical Oncology
2016;
5
(2)
:19
.
(19 April 2016)
Clinical trials in nasopharyngeal carcinoma—past, present and future
Chinese Clinical Oncology
2016;
5
(2)
:20
.
(19 April 2016)
Advances in systemic treatment for nasopharyngeal carcinoma
Chinese Clinical Oncology
2016;
5
(2)
:21
.
(19 April 2016)
Immunotherapy for nasopharyngeal cancer—a review
Chinese Clinical Oncology
2016;
5
(2)
:22
.
(19 April 2016)
Therapeutic vaccination strategies to treat nasopharyngeal carcinoma
Chinese Clinical Oncology
2016;
5
(2)
:23
.
(19 April 2016)
Clinical significance of hypoxia in nasopharyngeal carcinoma with a focus on existing and novel hypoxia molecular imaging
Chinese Clinical Oncology
2016;
5
(2)
:24
.
(19 April 2016)
Proton therapy for nasopharyngeal carcinoma
Chinese Clinical Oncology
2016;
5
(2)
:25
.
(19 April 2016)
Reirradiation of locally recurrent nasopharyngeal cancer: history, advances, and promises for the future
Chinese Clinical Oncology
2016;
5
(2)
:26
.
(19 April 2016)
The International Atomic Energy Agency global initiatives on nasopharyngeal cancer treatment
Chinese Clinical Oncology
2016;
5
(2)
:27
.
(19 April 2016)
Korean perspectives of nasopharynx cancer management
Chinese Clinical Oncology
2016;
5
(2)
:28
.
(19 April 2016)
Closing Editorial
Nasopharyngeal carcinoma—some closing remarks
Chinese Clinical Oncology
2016;
5
(2)
:29
.
(19 April 2016)
Disclosure:
The focused issue “Nasopharyngeal Carcinoma” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Joseph Wee, Yoke-Lim Soong and Melvin Chua served as the unpaid Guest Editors for the focused issue.
